About Francisco R Breijo Marquez
Prof. Dr. FR Breijo Marquez holds a Doctorate in Medicine from the University of Boston and Hartford (MA and CT), where he is also a Professor of Clinical & Experimental Cardiology. He is currently the Director of Doctoral Theses on Clinical and Experimental Cardiology as Research Director at both East Boston and Hartford Universities. He is an advisory board member and an editorial board member for several scientific journals. He has published several Textbooks on Cardiology.
Primary Specialty
Profession/Role
Sign up to receive important communications for authors from Lippincott
Intro Content
Published Author
Misuse of the Drug Acenocoumarol in a Population of 250 Inhabitants with Non-valvular Atrial Fibrillation Assessed in a Region of Southeaster of Spain
Spain is one of the few countries in Europe that still prescribes Acenocoumarol, similar to warfarin.
Influencer Of
Popular Content
Spain is one of the few countries in Europe that still prescribes Acenocoumarol, similar to warfarin.
Recent Comments
In my view, open access journals are only interested in the profits they make, without giving a damn about the scientific rigor and originality of the manuscripts. Including the so-called high impact journals (BMJ, for example).
Nowadays, there are more publications than time to read them.
It is really awful.
Writing a review to any newspaper is a good idea. Some people don't have social networks.
It’s useful for me, thank you
Thank you very much, comrade Mengmeng dou I also trust that it may be useful to other interested readers.
In my view, publishing more than one article a year is vulgar and shows the egocentric need of the author, especially if it is in an open access journal. No offense to anyone.
With all due respect, I have the impression that I am on a wrong link.
Generally— in fact, unanimous, —open access journals, are very valid for those authors who do not manage to publish in high-impact index journals and intend to appear in the famous Google Scholar.
Everything you have written is phenomenal, absolutely everything. However, why have prestigious journals with high-impact indexes been inclined to launch “open access” publications as well? In my opinion, as a full professor of medicine, the field of medicine is becoming increasingly commercialized every day. The trend seems to be that the more you pay, the more you get published.
Everything you have written is phenomenal, absolutely everything. However, why have prestigious journals with high-impact indexes been inclined to launch “open access” publications as well? In my opinion, as a full professor of medicine, the field of medicine is becoming increasingly commercialized every day. The trend seems to be that the more you pay, the more you get published.